Literature DB >> 2908709

Left ventricular function and beta-blockers: does intrinsic sympathomimetic activity have any influence during chronic therapy?

R J Northcote1, M B Cooke, D Ballantyne.   

Abstract

A study comparing the chronic effects of propranolol (n = 21) and pindolol (n = 19) on male patients with stable angina pectoris was performed. Left ventricular function was assessed by serial radionuclide ventriculography. Radionuclide ventriculography was performed at rest and during cold pressor test. Both drugs improved symptoms of angina pectoris by at least one division of the New York Heart Association classification. Cold pressor testing caused increases in heart rate and blood pressure in both groups throughout the study. At rest, pretreatment ejection fraction was similar in both groups. During propranolol treatment this rose sequentially from 49% to 55% at 26 weeks. No change in the resting ejection fraction occurred in those taking pindolol. The difference in response between the groups reached significance at 26 weeks. In those with subnormal left ventricular ejection fraction (less than 50%), resting ejection fraction improved significantly throughout treatment with propranolol rising from a basal value of 39% to 51% at 26 weeks. In comparison, pindolol caused no significant change. There is no apparent advantage to intrinsic sympathomimetic activity in terms of preservation or improvement of left ventricular performance in patients with stable angina pectoris prescribed beta-blockers for extended periods of time.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2908709     DOI: 10.1007/BF00051195

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  35 in total

1.  Noninvasive assessment of clinical response to oral propranolol therapy.

Authors:  W Frishman; C Smithen; B Befler; P Kligfield; T Killip
Journal:  Am J Cardiol       Date:  1975-05       Impact factor: 2.778

2.  Effects of oral propranolol in normal subjects.

Authors:  M M LeWinter; M H Crawford; J S Karliner; R A ORourke
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

3.  How useful are the cold pressor test and sustained isometric handgrip exercise with radionuclide ventriculography in the evaluation of patients with coronary artery disease?

Authors:  R J Northcote; M B Cooke
Journal:  Br Heart J       Date:  1987-04

4.  Abnormalities of left ventricular contraction induced by beta adrenergic blockade.

Authors:  R H Helfant; M V Herman
Journal:  Circulation       Date:  1971-05       Impact factor: 29.690

5.  Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease.

Authors:  S H Taylor; B Silke; P S Lee; A Hilal
Journal:  Eur Heart J       Date:  1982-12       Impact factor: 29.983

6.  A fully automated determination of the left ventricular region of interest in nuclear angiocardiography.

Authors:  M L Goris; J H McKillop; P A Briandet
Journal:  Cardiovasc Intervent Radiol       Date:  1981       Impact factor: 2.740

7.  The radionuclide ejection fraction: a comparison of three radionuclide techniques with contrast angiography.

Authors:  E D Folland; G W Hamilton; S M Larson; J W Kennedy; D L Williams; J L Ritchie
Journal:  J Nucl Med       Date:  1977-12       Impact factor: 10.057

8.  Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography.

Authors:  R D Burow; H W Strauss; R Singleton; M Pond; T Rehn; I K Bailey; L C Griffith; E Nickoloff; B Pitt
Journal:  Circulation       Date:  1977-12       Impact factor: 29.690

9.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

10.  In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization.

Authors:  D G Pavel; M Zimmer; V N Patterson
Journal:  J Nucl Med       Date:  1977-03       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.